Orion Corporation B (ORNBV.HE) Financials
ORNBV.HE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 1.4 billion | 548.5 million |
| 2023-09-30 | 1.4 billion | 531.7 million |
| 2023-06-30 | 1.3 billion | 539.9 million |
| 2023-03-31 | 1.3 billion | 564.3 million |
ORNBV.HE Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 26.7 million | ? |
| 2023-09-30 | 9.7 million | ? |
| 2023-06-30 | 15.7 million | ? |
| 2023-03-31 | -49.8 million | ? |
ORNBV.HE Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 75.1 million |
| 2023-09-30 | 61.4 million |
| 2023-06-30 | 45.8 million |
| 2023-03-31 | 55.1 million |
ORNBV.HE Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 8.1 million |
| 2023-09-30 | 77.9 million | 176.8 million | - |
| 2023-06-30 | 74.6 million | 183.2 million | - |
| 2023-03-31 | 99.8 million | 189.7 million | - |
ORNBV.HE Shares Outstanding
ORNBV.HE Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 22.1 million | 36.6 million | 83.1 million | - |
| 2023-09-30 | 94.7 million | 27.2 million | 64.4 million | - |
| 2023-06-30 | 17.5 million | 31.3 million | 21.6 million | 58.9 million |
| 2023-03-31 | 53.8 million | 31.7 million | 17.8 million | 53.8 million |
ORNBV.HE Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 321.1 million | 144.3 million |
| 2023-09-30 | 301.1 million | 129.8 million |
| 2023-06-30 | 289.5 million | 136.0 million |
| 2023-03-31 | 278.0 million | 121.8 million |
ORNBV.HE
Price: €35.85
Dividend Yield: 0.05%
Forward Dividend Yield: 2.26%
Payout Ratio: 65.32%
Dividend Per Share: 0.81 EUR
Earnings Per Share: 1.54 EUR
P/E Ratio: 34.44
Exchange: HEL
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 133356
Market Capitalization: 4.7 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: -14.44%
DGR5: 12.02%
DGR10: 7.15%
DGR20: 30.00%